This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Neurology  • Headache  • Migraine  • Alert me on articles by topic  Social Bookmarking   What's this?

Jennifer Daley, MD; Thomas L. Delbanco, MD; Erin E. Hartman, MS

JAMA. 1998;279:954.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

At Medicine Grand Rounds in April 1997, Dr K. M. A. Welch discussed the options for a 27-year-old woman with migraine headaches that had occurred up to 5 times per month.¹ At that time, use of -blockers had decreased the frequency of her migraines to 1 per month just prior to her menses.

Dr Welch described the common triggers of migraine attacks as well as their diagnosis, epidemiology, and pathogenesis. He provided a detailed approach to the management of migraines, including both abortive and preventive use of different medications. Dr Welch suggested that Mrs D, the patient, might get better relief of her migraines by following her sumatriptan succinate injection with an oral form of the drug, and that she might also benefit from prophylactic use of a nonsteroidal anti-inflammatory agent prior to the onset of her menses. We . . . [Full Text of this Article]

MRS D, THE PATIENT

DR N, THE PRIMARY PHYSICIAN

From the Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, 330 Brookline Ave, LY318, Boston, MA 02215.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?